Press releases

Altroconsumo and Volkswagen terminate amicably the class action case on fuel consumption data

The vehicle model involved is “Golf” 1.6 TDI Blue Motion Technology Euro 5.

Euroconsumers Sends Cease and Desist Letter to Apple Over Planned Obsolescence

Letter calls on Apple to end practice and compensate consumers € 60 each

German courts confirm Dieselgate ruling but millions of consumers are yet to be compensated

Euroconsumers reminds Volkswagen that Dieselgate is an international scandal. All victims deserve to be treated equally.

Travel sector crisis. Ministers do not weaken consumer rights

Ahead of this week’s video-conference meeting of EU Tourism and Transport Ministers.
Euroconsumers is calling for coordinated measures to tackle the on-going travel sector crisis.
A solution needs to be found for both consumers and business.
The COVID-19 crisis should not be used to diminish consumers’ rights. Restoring consumer trust in the Single Market is essential for the recovery of all European economies.

Euroconsumers announces inaugural BeXt Award Winners at its International Forum

Bridging the Gap between Consumers and Businesses in the Digital Age.
Euroconsumers’ new BeXt Awards were presented at its First International Forum, held today, 12 November, at the Claridge in Brussels.

Together to improve the digital ecosystem

Google and Euroconsumers join forces to improve consumers’ digital empowerment, through joint research, events and campaigns.

Euroconsumers announces Euroconsumers BeXt Awards

Euroconsumers announces Euroconsumers BeXt Awards to recognise the brands that have made significant contributions to improving the global marketplace over the year. 

The winners will be announced at Euroconsumers’ first International Forum  Bridging the Gap between Consumers and Businesses [in the Digital Age] 

Bridging the Gap between Consumers and Businesses in the Digital Age

Euroconsumers’ First International Forum.

Spinraza unfairly priced. Italian and belgian antitrust authotrities urged to investigate on drug

Altroconsumo and Test-Achats report yet another case of exorbitant pricing of innovative drugs.

The case of Spinraza, manufactured by the multinational corporation Biogen for the treatment of SMA (spinal muscular atrophy), a rare and otherwise incurable disease, has been reported to Competition Authorities in Italy and Belgium.

In just two years on the market, as shown by an investigation conducted by the two consumer organizations, for every dollar invested, four has already returned to Biogen. Even worse, its market exclusivity will last until 2029.

Avastin-Lucentis: the Council of State confirms the sentences for Roche and Novartis

This puts an end to a sequence of events starting back in 2009, which has seen Altroconsumo at the forefront since the very beginning. The Council of State has today marked the point of no return: Roche and Novartis are guilty of unlawful collusion, to the detriment of patients and the national health system.

Now we hope that appeals from the regions will get underway.